SINGLE-CELL SEQUENCING ANALYSIS OF THE CELLULAR LANDSCAPE AND INTER-CLONAL CROSSTALK IN CONCURRENT CLL/SLL AND CML

EHA Library, jiaojiao zhang, 4209425

NEXT-GENERATION SEQUENCING-BASED ASSESSMENT OF GENE DIVERSITY IN CHRONIC LYMPHOCYTIC LEUKEMIA: A SINGLE-CENTER EXPERIENCE

EHA Library, Vojin Vukovic, 4209436

PERSISTENT LYMPHOCYTOSIS AS A DIAGNOSTIC CHALLENGE: TWO CLINICAL CASES OF T- AND B-CELL LYMPHOID PROLIFERATION

EHA Library, Raquel Lopes, 4209437

DURATION OF TREATMENT-FREE REMISSION AFTER FIXED DURATION THERAPY IN CHRONIC LYMPHOCYTIC LEUKEMIA: A REAL-WORLD ANALYSIS

EHA Library, Mattia D'Antiga, 4209440

RETROSPECTIVE EVALUATION OF THE G8 SCORE IN CLL PATIENTS TREATED WITH TARGETED THERAPIES: A MULTI-CENTER EXPERIENCE

EHA Library, Alessandro Sanna, 4209441

LANDSCAPE OF LATENT TUBERCOLOSIS INFECTION (LTBI) IN CHRONIC LYMPHOCYTIC LEUKEMIA. AN ITALIAN CLL CAMPUS STUDY.

EHA Library, Andrea Visentin, 4209442

REAL-WORLD EFFECTIVENESS AND TOLERABILITY OF ACALABRUTINIB IN CHRONIC LYMPHOCYTIC LEUKEMIA: A MULTICENTER REAL-LIFE EXPERIENCE

EHA Library, Andrea Duminuco, 4209445

INDIRECT COMPARISON OF ZANUBRUTINIB VS ACALABRUTINIB AND IBRUTINIB EFFICACY IN PATIENTS WITH TREATMENT-NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Mazyar Shadman, 4209446

LOW-NORMAL IMMUNOGLOBULIN LEVELS SUGGEST MONOCLONAL B-CELL LYMPHOCYTOSIS AND CONSTITUTIONAL CLL SUSCEPTIBILITY: A DUAL-MECHANISM ANALYSIS

EHA Library, Ramon Cohen, 4209448

AN INTERPRETABLE MACHINE LEARNING MODEL FOR THERAPY FAILURE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING BRUTON’S TYROSINE KINASE INHIBITORS

EHA Library, Yutang Li, 4209450

COMORBIDITIES AND TREATMENT PATTERNS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN LITHUANIA, 2021–2024

EHA Library, Migle Kulbokė, 4209451

REAL-WORLD OUTCOMES AMONG MEDICARE BENEFICIARIES TREATED WITH FIRST-LINE (1L) BRUTON TYROSINE KINASE INHIBITORS (BTKIS) FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Daniel Ermann, 4209452

PROFILE OF PATIENTS USING ACALABRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKEMIA IN REAL-LIFE SETTINGS IN ROMANIA: TREATMENT-NAÏVE AND RELAPSE/REFRACTORY COHORTS FROM THE NON-INTERVENTIONAL STUDY REACH

EHA Library, Ciprian Tomuleasa, 4209457

REVACCINATION WITH CONJUGATED PNEUMOCOCCAL VACCINE IMPROVES FUNCTIONALITY OF VACCINE MEDIATED ANTIBODIES IN CHRONIC LYMPHOCYTIC LEUKEMIA.

EHA Library, Simon Golowin, 4209458

REAL-WORLD OUTCOMES OF ACALABRUTINIB MONOTHERAPY FOR CHRONIC LYMPHOCYTIC LEUKAEMIA IN THE WEST OF SCOTLAND

EHA Library, Sidhant Seth, 4209459

PATIENT-REPORTED OUTCOMES AND DISEASE PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL LYMPHOCYTIC LYMPHOMA: A SYSTEMATIC LITERATURE REVIEW AND GAP ANALYSIS

EHA Library, Loic Ysebaert, 4209460

PIRTOBRUTINIB VERSUS SECOND-GENERATION BTK INHIBITORS IN RELAPSED/REFRACTORY CLL/SLL: A BAYESIAN NETWORK META-ANALYSIS.

EHA Library, stefano molica, 4209461

CONCORDANCE OF MEASURABLE RESIDUAL DISEASE (MRD) RATES IN THE PERIPHERAL BLOOD AND BONE MARROW AFTER FIRST-LINE TREATMENT FOR CLL: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Graham Wehmeyer, 4209462

REAL-WORLD INTRAVENOUS IMMUNOGLOBULIN (IVIG) UTILIZATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL) TREATED WITH VENETOCLAX PLUS OBINUTUZUMAB VS ZANUBRUTINIB

EHA Library, Nicole Lamanna, 4209466

A GLOBAL MULTICENTER, OPEN-LABEL, RANDOMIZED, PHASE 3 REGISTRATIONAL STUDY OF LISAFTOCLAX (APG-2575) IN PREVIOUSLY TREATED CLL/SLL: GLORA TRIAL IN PROGRESS

EHA Library, Matthew Davids, 4209467

SPECTRUM OF AUTO- AND ALLOANTIBODIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND THEIR IMPACT ON TRANSFUSION THERAPY TACTICS (PRELIMINARY DATA)

EHA Library, Karina Manucharova, 4209470

CONCOMITANT USE OF VENETOCLAX 100MG AND KETOCONAZOLE IS CLINICALLY EQUIVALENT TO VENETOCLAX 400MG FOR TREATING RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL).

EHA Library, Celso Arrais-Rodrigues, 4209471

BGB-16673 VERSUS IDELALISIB + RITUXIMAB (R), BENDAMUSTINE + R, OR VENETOCLAX + R RE-TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA: THE PHASE 3 CADANCE-302 TRIAL

EHA Library, Paolo Ghia, 4209476

FINAL ANALYSIS OF AUTOIMMUNE CYTOPENIAS IN A SERIES OF PATIENTS AFFECTED BY CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH ACALABRUTINIB

EHA Library, Andrea Ferrario, 4209479

A RETROSPECTIVE ANALYSIS OF ORELABRUTINIB MONOTHERAPY AFTER OTHER BRUTON'S TYROSINE KINASE INHIBITORS EXPOSURE IN CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA

EHA Library, Kai Shen, 4209480

PRIMARY CARE MANAGEMENT PATHWAYS TO REDUCE WAIT TIMES IN HEMATOLOGY: LYMPHOCYTOSIS AND LYMPHOPENIA

EHA Library, Sarah Ryan, 4209483

UNDERSTANDING PATIENTS' PERSPECTIVES AND PREFERENCES REGARDING FIRST-LINE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATMENT ACROSS EUROPE

EHA Library, Lydia Scarfò, 4209484

TREATMENT PATTERNS, AND SURVIVAL OUTCOMES OF PATIENTS AGED ≥80 YEARS WITH CLL: DATA FROM THE BRAZILIAN REGISTRY OF CLL (RBLLC).

EHA Library, Thiago Carneiro, 4209488

LONGITUDINAL SHIFTS IN TREATMENT SELECTION AND SEQUENCING IN CLL: EVIDENCE ALIGNMENT AND INTEGRATION OF PATIENT PREFERENCES

EHA Library, Carmine DeLuca, 4209492

NUMBER OF DEATHS AVOIDED WITH USE OF ZANUBRUTINIB VERSUS IBRUTINIB FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN EUROPE

EHA Library, Talha Munir, 4209494

CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF RICHTER TRANSFORMATION AND CLL ACCELERATION: A 15-YEAR SINGLE-CENTER EXPERIENCE

EHA Library, Maria Kislova, 4209496

SIGNIFICANT IMPROVEMENT OF DISEASE-SPECIFIC OVERALL SURVIVAL IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: ANALYSIS OF AN UNSELECTED COHORT FROM THE HRADEC KRÁLOVÉ DISTRICT, CZECH REPUBLIC.

EHA Library, Lukáš Smolej, 4209497

TIME TO NEXT TREATMENT ACCORDING TO SECOND-LINE REGIMEN FOR CHRONIC LYMPHOCYTIC LEUKEMIA: A RETROSPECTIVE ANALYSIS OF THE BRAZILIAN REGISTRY OF CLL

EHA Library, Marcelo Pitombeira De Lacerda, 4209498

EARLY TREATMENT-PHASE CARE DELIVERY BURDEN WITH VENETOCLAX-BASED VERSUS BTK INHIBITOR–BASED REGIMENS IN TREATMENT-NAÏVE CLL

EHA Library, Truman Koh, 4209499

A STUDY OF BEXOBRUTIDEG (NX-5948), A BTK DEGRADER, IN PATIENTS WITH CLL/SLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITOR, A NON-COVALENT BTK INHIBITOR AND A BCL2 INHIBITOR: DAYBREAK CLL-201

EHA Library, Dima El-Sharkawi, 4209501

CHRONIC LYMPHOCYTIC LEUKEMIA IN A RESOURCE-LIMITED SETTING: EXPERIENCE FROM NORTHERN MOROCCO

EHA Library, Tarik Arahou, 4209502

REAL-WORLD EFFICACY AND CARDIOVASCULAR SAFETY OF ACALABRUTINIB IN B-CELL MALIGNANCIES: A TURKISH MULTICENTER EXPERIENCE COMPARING FRONTLINE INITIATION VS. TRANSITION AFTER IBRUTINIB INTOLERANCE

EHA Library, Vildan Gursoy, 4209503

CLL2000: A PROSPECTIVE PLATFORM FOR LONG-TERM OUTCOMES AND TREATMENT SEQUENCING OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AFTER FIRST-LINE THERAPY WITHIN GCLLSG STUDIES

EHA Library, Kirsten Fischer, 4209504

CD20 EXPRESSION LEVEL AS A FACTOR IN THE SELECTION OF MONOCLONAL ANTIBODIES FOR THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA.

EHA Library, Morozova Oksana, 4209505

CHARACTERISTICS AND 5-YEAR OUTCOMES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING IBRUTINIB (A REAL-WORLD STUDY)

EHA Library, Umida Ergasheva, 4209506

REAL-WORLD OUTCOMES OF FIRST-LINE CHEMOIMMUNOTHERAPY FOR CLL IN KAZAKHSTAN: IMPACT OF IGHV STATUS AND TP53 ABERRATIONS

EHA Library, Lyudmila Turgunova, 4209507

SECONDARY BREAST INVOLVEMENT BY CHRONIC LYMPHOCYTIC LEUKEMIA IN A MALE PATIENT: A RARE PRESENTATION WITH MOLECULAR CORRELATES

EHA Library, Karla Fernanda Rodriguez Estrada, 4209509

CONCOMITANT DIAGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA AND B-LYMPHOBLASTIC LEUKEMIA IN A 68-YEAR-OLD MAN: AN EXTREMELY RARE CASE OF BILINEAL ACUTE TRANSFORMATION

EHA Library, Marsela Shani, 4209511

RICHTER SYNDROME IN ROUTINE CLINICAL PRACTICE: A SINGLE TERTIARY-CENTER EXPERIENCE

EHA Library, Bernardo Soto Román, 4209512

ROCKET-CLL: A RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE 3 STUDY OF ROCBRUTINIB (LP-168) VERSUS PIRTOBRUTINIB IN COVALENT BTK INHIBITOR (CBTKI) PRETREATED RELAPSED OR REFRACTORY (R/R) CLL/SLL

EHA Library, Yu Chen, 4209515

LEPTOMENINGEAL INVOLVEMENT IN NEWLY DIAGNOSED CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Gabriela Diana Cantor, 4209519

IMMUNOPHENOTYPIC AND MOLECULAR BIOLOGICAL MARKERS  BASED RISK STRATIFICATION OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA,

EHA Library, Morozova Oksana, 4209520

FACTORS PREDICTING PULMONARY INFECTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATED WITH TARGETED THERAPIES WITH A HISTORY OF LUNG DISEASES: FACTORS ARE IGHV, TP53 (LOW AND HIGH BURDEN)

EHA Library, Maher Salamoon, 4209522

OUTCOME OF FIRST-LINE VENETOCLAX THERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. SINGLE-CENTER EXPERIENCE.

EHA Library, Morozova Oksana, 4209523

MOLECULAR REMISSION AFTER TYROSINE KINASE INHIBITOR CESSATION IN CHRONIC MYELOID LEUKEMIA (CML): A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Songphol Tungjitviboonkun, 4209527

BIOCHEMICAL AND MOLECULAR-GENETIC ARRAYS OF CHRONIC MYELOID LEUKEMIA: MANAGEMENT AND PROGNOSIS IMPACT

EHA Library, Vasile Musteata, 4209529

DEVELOPMENT AND EVALUATION OF A NOVEL EXOSOME–SULFORAPHANE FORMULATION FOR ANTI-CANCER ACTIVITY IN CHRONIC MYELOID LEUKAEMIA

EHA Library, BANAN ALKHATAYBEH, 4209530

RESULTS OF TWO-STEP REDUCED-DOSE TKI THERAPY FOLLOWED BY TREATMENT-FREE OBSERVATION IN CML PATIENTS IN READIT (STUDY OF REDUCTION AND DISCONTINUATION TREATMENT OF TKI) AND POST-STUDY FOLLOW-UP

EHA Library, Ekaterina Chelysheva, 4209532

NINE-YEARS FOLLOW-UP OF THE PHASE I/II TRIAL OF IMATINIB DISCONTINUATION AFTER PIOGLITAZONE (EDI-PIO) IN CHRONIC MYELOID LEUKEMIA PATIENTS IN DEEP MOLECULAR RESPONSE

EHA Library, Katia Pagnano, 4209535

ULTRA-EARLY MOLECULAR RESPONSE AT 6 WEEKS OF ASCIMINIB THERAPY FOR PATIENTS WITH NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA

EHA Library, Bingbing Wen, 4209536

GUT MICROBIOME IN PATIENTS WITH UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA AND ASSOCIATIONS WITH BASELINE CLINICAL AND MOLECULAR FEATURES

EHA Library, Yajuan Gao, 4209426

LONG-READ NANOPORE SEQUENCING: A RAPID AND HIGHLY ACCURATE APPROACH FOR IGHV GENE ANALYSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Leily Rabbani, 4209427

CIRCULATING MIRNA SIGNATURE TRACKS DISEASE PROGRESSION AND TARGETED THERAPY RESPONSE IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Mariam Ibáñez Company, 4209430

ADVANCED MRD ANALYSIS AND IMMUNOLOGICAL MONITORING IN RELAPSED CLL PATIENTS RECEIVING RITUXIMAB-VENETOCLAX: RESULTS FROM THE “DEDALUS” STUDY

EHA Library, Maria D’Amato, 4209431

INTEGRATING EPIDEMIOLOGICAL INTELLIGENCE AND MULTI-OMICS PERSPECTIVES: ADVANCING BIOMARKER-DRIVEN STRATEGIES AGAINST THE GLOBAL BURDEN OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Zi Wang, 4209432

A COMPARISON OF FULL-LENGTH VDJ AND CONVENTIONAL CDR3-BASED CLONAL CLUSTERING METHODS FOR EVALUATING SUB-CLONAL COMPOSITION IN CLL

EHA Library, Loubna BOUTKHIL, 4209434

TARGETED NGS REVEALS THE MUTATIONAL LANDSCAPE OF UNTREATED WATCH-AND-WAIT CLL PATIENTS IN A REAL-WORLD BRAZILIAN COHORT

EHA Library, Pedro Henrique Fernandes do Carmo Las Casas, 4209435

ORELABRUTINIB MONOTHERAPY IN CHINESE PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A MULTI-CENTER REAL-WORLD RETROSPECTIVE STUDY

EHA Library, Huayuan Zhu, 4209438

BASELINE CHOLESTATIC LIVER ENZYME ELEVATION INDEPENDENTLY PREDICTS INFERIOR OVERALL SURVIVAL IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A NATIONWIDE REAL-WORLD COHORT STUDY

EHA Library, Yotam Bronstein, 4209443

RISK OF TUMOR LYSIS SYNDROME AMONG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA OR MANTLE CELL LYMPHOMA TREATED WITH VENETOCLAX: A REAL-WORLD STUDY

EHA Library, Alessandra Ferrajoli, 4209447

REAL-WORLD EXPERIENCE WITH ZANUBRUTINIB IN CHRONIC LYMPHOCYTIC LEUKAEMIA – PATIENT PROFILE, TREATMENT PATTERNS, AND SAFETY: PRELIMINARY ANALYSIS OF FRENCH ROZALY STUDY

EHA Library, Florian Bouclet, 4209449

FROM INNATE RESERVE TO HUMORAL COLLAPSE: DETERMINANTS OF SEVERE INFECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Carmen Dbouk Y Jaudenes, 4209453

MINIMAL RESIDUAL DISEASE TRENDS AMONG CLL PATIENTS TREATED WITH BRUTON’S TYROSINE KINASE INHIBITORS

EHA Library, Laura Samples, 4209455

REAL-WORLD OUTCOMES OF CONTINUOUSLY REDUCED-DOSE ZANUBRUTINIB MONOTHERAPY IN CLL/SLL: A MULTI-CENTER RETROSPECTIVE STUDY

EHA Library, Kai Shen, 4209456

SHORTENED OBINUTUZUMAB INFUSION IN FRONTLINE CLL: REDUCED CHAIR TIME WITHOUT COMPROMISING SAFETY

EHA Library, Eva Vejrazkova, 4209463

EFFECTIVENESS AND SAFETY OF FIXED-DURATION VERSUS CONTINUOUS THERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A SINGLE-TERTIARY-CENTER RETROSPECTIVE ANALYSIS

EHA Library, Arianna Bevilacqua, 4209469

A TIME-LIMITED STRATEGY COMBINING ORELABRUTINIB WITH SHORT-COURSE BENDAMUSTINE-RITUXIMAB AS FIRST-LINE THERAPY FOR CHRONIC LYMPHOCYTIC LEUKEMIA: A PROSPECTIVE MULTICENTER STUDY

EHA Library, Linlin Cao, 4209473

DISCRETE CHOICE EXPERIMENT FOR TREATMENT PREFERENCES IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Alex Cornelisse, 4209474

INCIDENCE OF SECOND PRIMARY MALIGNANCIES IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Regina Zsigmond, 4209475

BEYOND CLINICAL TRIALS: CARDIOVASCULAR RISK FACTORS AND ADVERSE EVENTS IN PATIENTS WITH CLL TREATED WITH BTK INHIBITORS IN A MULTICENTRE REAL-LIFE ITALIAN COHORT

EHA Library, Andrea Serafin, 4209477

IMPACT OF MEASURABLE RESIDUAL DISEASE IN HAIRY CELL LEUKEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Francesco Angotzi, 4209478

REAL-WORLD EFFICACY AND SAFETY DATA OF ORELABRUTINIB MONOTHERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTICLEUKEMIA: A  SINGLE-CENTER RETROSPECTIVE STUDY

EHA Library, Kai Shen, 4209481

EFFICACY OF VENETOCLAX-BASED REGIMENS IN PATIENTS WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA AFTER CHEMOIMMUNOTHERAPY: A MULTICENTER STUDY IN RUSSIA

EHA Library, Maria Kislova, 4209486

REAL-WORLD CARDIOVASCULAR EVALUATION AND BURDEN IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) INITIATED ON ACALABRUTINIB IN ROMANIA: RESULTS OF THE NON-INTERVENTIONAL STUDY REACH

EHA Library, Mihaela Andreescu, 4209487

ANCHOR: FIXED-DURATION SONROTOCLAX AND ZANUBRUTINIB IN CLL/SLL PATIENTS PREVIOUSLY TREATED WITH BTKI MONOTHERAPY, A MULTICENTER, PHASE II STUDY

EHA Library, Haiwen Huang, 4209489

RICHTER TRANSFORMATION IN CHRONIC LYMPHOCYTIC LEUKEMIA: CHARACTERISTICS, TREATMENT AND OUTCOMES IN A SINGLE-CENTER COHORT OF 57 PATIENTS OVER 25 YEARS

EHA Library, Alexandros Machairas, 4209490

EFFICACY AND TOLERABILITY OF VENETOCLAX PLUS RITUXIMAB IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA – REAL-WORLD ANALYSIS OF THE POLISH ADULT LEUKEMIA STUDY GROUP AND THE CZECH CLL STUDY GROUP

EHA Library, Bartosz Puła, 4209491

PATIENT CHARACTERISTICS, GENETIC PROFILING, AND TREATMENT PATTERNS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN LITHUANIA, 2021–2024

EHA Library, Regina Pileckyte, 4209495

SURVIVAL IN VERY ELDERLY (≥75 YEARS) PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: MULTINATIONAL REAL-WORLD ANALYSIS FROM LATIN AMERICA

EHA Library, Thiago Carneiro, 4209500

EFFECTIVENESS OF SUBCUTANEOUS CLADRIBINE IN HAIRY CELL LEUKEMIA: A MULTICENTER REAL-WORLD STUDY FROM BRAZIL

EHA Library, Celso Arrais-Rodrigues, 4209508

FDG PET-CT IN HAIRY CELL LEUKEMIA: DEFINING STANDARD METABOLIC UPTAKE ACROSS DISEASE COMPARTMENTS

EHA Library, Tamar Tadmor, 4209510

EFFICACY AND SAFETY OF VENETOCLAX IN PREDOMINANTLY HEAVILY PRETREATED CLL PATIENTS: A REAL-WORLD SINGLE-CENTER EXPERIENCE

EHA Library, Darko Aleksic, 4209513

IBRUTINIB MAINTENANCE AFTER FIRST-LINE CHEMOIMMUNOTHERAPY IN CLL: A PROSPECTIVE MULTICENTER STUDY

EHA Library, Nayara Guedes, 4209514

SONROTOCLAX (BGB-11417) + ZANUBRUTINIB VS VENETOCLAX + ACALABRUTINIB IN TREATMENT-NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA: A PHASE 3 RANDOMIZED TRIAL DESIGN (CELESTIAL-TNCLL-2)

EHA Library, Mazyar Shadman, 4209516

CLINICAL CHARACTERISTICS AND PROGNOSIS ANALYSIS OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Xiangli Wang, 4209517

EFFICACY OF TARGETED THERAPY IN CHRONIC LYMPHOCYTIC LEUKEMIA ACROSS DIFFERENT LINES OF TREATMENT: A REAL-WORLD PRACTICE ANALYSIS

EHA Library, Evgenii Kunevich, 4209518

IGHV STATUS DEFINES A MARROW-DOMINANT PROGRESSION PHENOTYPE IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Maria Bacanu, 4209521

TREATMENT-FREE REMISSION (TFR) FOR NEWLY DIAGNOSED ACCELERATED PHASE CML (AP-CML)

EHA Library, Franck Emmanuel Nicolini, 4209525

SINGLE-CELL TRANSCRIPTOMIC AND CYTOGENETIC INSIGHTS IN A RARE VARIANT OF CHRONIC MYELOID LEUKEMIA SUGGEST A METABOLICALLY “PROTECTED” PHENOTYPE

EHA Library, Irene Serrano-Gonzalo, 4209526

COMPLEX VARIANT TRANSLOCATIONS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Olena Zotova, 4209528

IMPACT OF BASOPHILIA AND EOSINOPHILIA ON IMATINIB RESISTANCE IN CHRONIC MYELOID LEUKEMIA

EHA Library, Siham Belkadi, 4209531

MANAGEMENT OF CML AND SECOND PRIMARY MALIGNANCIES IN THE ERA OF MODERN THERAPIES: REAL-WORLD STRATEGIES AND IMPACT ON CLINICAL OUTCOMES.

EHA Library, Gianni Binotto, 4209533

TKI DOSE INTENSITY AND TREATMENT DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A SINGLE CENTER ANALYSIS

EHA Library, Daniele Sannipoli, 4209534

PREDICTORS OF OUTCOMES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN LYMPHOID BLAST PHASE IN THE MODERN ERA

EHA Library, Nicholas Short, 4209537

PROSPECTIVE VALIDATION AND CLINICAL FOLLOW-UP OF DIGITAL PCR FOR BCR::ABL1 QUANTIFICATION IN CHRONIC MYELOID LEUKAEMIA IN CHRONIC PHASE (CML-CP)

EHA Library, Trung Ngo, 4209538